BRCA
From Proteopedia
(Difference between revisions)
Line 18: | Line 18: | ||
</StructureSection> | </StructureSection> | ||
- | ==3D structures of BRCA== | ||
- | |||
- | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
- | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | |||
- | *BRCA1 | ||
- | |||
- | **[[4ofb]], [[4y18]], [[4y2g]], [[4u4a]], [[4jlu]], [[4ifi]], [[4igk]], [[3k0h]], [[3k0k]], [[3coj]], [[1y98]], [[1t15]], [[1t29]], [[1t2v]] - hBRCA1 BRCT1 domain + peptide inhibitor - human<br /> | ||
- | **[[3pxa]], [[3pxb]], [[3pxc]], [[3pxd]], [[3pxe]], [[3k15]], [[3k16]] - hBRCA1 BRCT1 domain (mutant) + peptide inhibitor<br /> | ||
- | **[[1jnx]] - hBRCA1 BRCT domain<br /> | ||
- | **[[2ing]], [[1t2u]], [[1n5o]] - hBRCA1 BRCT1 domain (mutant)<br /> | ||
- | **[[1oqa]] - hBRCA1 BRCT-C domain - NMR<br /> | ||
- | **[[1l0b]] - BRCA1 BRCT domain - rat<br /> | ||
- | **[[2n9e]] - hBRCA1 SUMO-interacting motif + small ubiquitin-related modifier - NMR<br /> | ||
- | **[[4mkf]], [[4mkg]] - hBRCA1 SUMO-interacting motif - NMR<br /> | ||
- | **[[1jm7]] - hBRCA1 Ring domain + BARD1 ring domian - NMR<br /> | ||
- | |||
- | *BRCA2 | ||
- | |||
- | **[[1iyj]], [[1miu]] – hBRCA2 residues 2335-3151 + DSS1<br /> | ||
- | **[[1mje]] – hBRCA2 residues 2335-3151 + DSS1 + ssDNA<br /> | ||
- | **[[1n0w]] – hBRCA2 BRC repeat 4 + RAD51 + linker<br /> | ||
- | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Current revision
|
References
- ↑ Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer PMID:20301425
- ↑ Shen Y, Tong L. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1. Biochemistry. 2008 May 27;47(21):5767-73. Epub 2008 May 2. PMID:18452305 doi:10.1021/bi800314m
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky